Exact Mass: 512.9752

Exact Mass Matches: 512.9752

Found 21 metabolites which its exact mass value is equals to given mass value 512.9752, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

2,5-Diaminopyrimidine nucleoside triphosphate

({[({[(2R,3S,4R,5R)-5-[(2,5-diamino-6-oxo-1,6-dihydropyrimidin-4-yl)amino]-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid

C9H18N5O14P3 (513.0063)


2,5-Diaminopyrimidine nucleoside triphosphate is involved in folate biosynthesis. 2,5-Diaminopyrimidine nucleoside triphosphate is created from 2,5-Diaminopyrimidine nucleoside triphosphate by GTP cyclohydrolase I [EC:3.5.4.16] [HMDB] 2,5-Diaminopyrimidine nucleoside triphosphate is involved in folate biosynthesis. 2,5-Diaminopyrimidine nucleoside triphosphate is created from 2,5-Diaminopyrimidine nucleoside triphosphate by GTP cyclohydrolase I [EC:3.5.4.16].

   

2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine

[({[({5-[(2,5-diamino-6-oxo-3,6-dihydropyrimidin-4-yl)amino]-2,3-dihydroxy-4-oxopentyl}oxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C9H18N5O14P3 (513.0063)


2,5-Diamino-6-(5-triphosphoryl-3,4-trihydroxy-2-oxopentyl)-amino-4-oxopyrimidine is involved in folate biosynthesis. 2,5-Diamino-6-(5-triphosphoryl-3,4-trihydroxy-2-oxopentyl)-amino-4-oxopyrimidine is created from 2,5-Diaminopyrimidine nucleoside triphosphate by GTP cyclohydrolase I [EC:3.5.4.16]. 2,5-Diamino-6-(5-triphosphoryl-3,4-trihydroxy-2-oxopentyl)-amino-4-oxopyrimidine can be converted into 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine. triphosphate by GTP cyclohydrolase I [EC:3.5.4.16]. GTP cyclohydrolase I [EC:3.5.4.16] can also be converted to 6-(3-Triphosphoryl-1-methylglyceryl)-7-methyl-7,8-dihydrobiopterin. 2,5-Diamino-6-(5-triphosphoryl-3,4-trihydroxy-2-oxopentyl)-amino-4-oxopyrimidine is involved in folate biosynthesis. 2,5-Diamino-6-(5-triphosphoryl-3,4-trihydroxy-2-oxopentyl)-amino-4-oxopyrimidine is created from 2,5-Diaminopyrimidine nucleoside triphosphate by GTP cyclohydrolase I [EC:3.5.4.16]. 2,5-Diamino-6-(5-triphosphoryl-3,4-trihydroxy-2-oxopentyl)-amino-4-oxopyrimidine can be converted into 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine

   

Cefuzoname

7-[2-(2-Imino-2,3-dihydro-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-3-[(1,2,3-thiadiazol-5-ylsulphanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H15N7O5S4 (513.0018)


   
   
   

cefuzonam

cefuzonam

C16H15N7O5S4 (513.0018)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic A second generation cephalosporin antibiotic.

   

Heptadecafluoro-N-methyloctanesulphonamide

1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-methyloctane-1-sulfonamide

C9H4F17NO2S (512.9691)


   

trisodium,2-[bis[(2-hydroxy-5-sulfonatophenyl)methyl]amino]acetate

trisodium,2-[bis[(2-hydroxy-5-sulfonatophenyl)methyl]amino]acetate

C16H14NNa3O10S2 (512.9752)


   

Triethy benzyl ammonium tribromide

Triethy benzyl ammonium tribromide

C19H34Br3N (513.0241)


   
   

N-(4-bromophenyl)-3-(4-chlorophenyl)sulfonyl-2,5-dimethylbenzenesulfonamide

N-(4-bromophenyl)-3-(4-chlorophenyl)sulfonyl-2,5-dimethylbenzenesulfonamide

C20H17BrClNO4S2 (512.9471)


   

Perfluorodecaneamide

Perfluorodecaneamide

C10H2F19NO (512.9833)


   

7-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(thiadiazol-5-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(thiadiazol-5-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H15N7O5S4 (513.0018)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

(2S,3R,4R)-2-[(2R,3S,4R,5R,6R)-4,6-Dihydroxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2S,3R,4R)-2-[(2R,3S,4R,5R,6R)-4,6-Dihydroxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C12H19NO17S2 (513.0094)


   

2-O-sulfo-beta-L-threo-hex-4-enopyranuronosyl-(1->4)-beta-D-GlcpNS

2-O-sulfo-beta-L-threo-hex-4-enopyranuronosyl-(1->4)-beta-D-GlcpNS

C12H19NO17S2 (513.0094)


   

2-deoxy-4-O-alpha-L-threo-hex-4-enopyranuronosyl-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose

2-deoxy-4-O-alpha-L-threo-hex-4-enopyranuronosyl-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose

C12H19NO17S2 (513.0094)


   

Delta(4)-beta-D-GlcpA-(1->4)-D-GlcpNS6S

Delta(4)-beta-D-GlcpA-(1->4)-D-GlcpNS6S

C12H19NO17S2 (513.0094)


   

2-(Sulfoamino)-4-O-[(4,5-didehydro-2-O-sulfo-1-deoxy-beta-D-glucopyranuronic acid)-1-yl]-2-deoxy-D-glucopyranose

2-(Sulfoamino)-4-O-[(4,5-didehydro-2-O-sulfo-1-deoxy-beta-D-glucopyranuronic acid)-1-yl]-2-deoxy-D-glucopyranose

C12H19NO17S2 (513.0094)


   

(2R,3R,4R)-2-[(2R,3S,4R,5R,6S)-4,6-Dihydroxy-2-(hydroxymethyl)-5-(sulfoamino)oxan-3-yl]oxy-4,5-dihydroxy-3-sulfooxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2R,3R,4R)-2-[(2R,3S,4R,5R,6S)-4,6-Dihydroxy-2-(hydroxymethyl)-5-(sulfoamino)oxan-3-yl]oxy-4,5-dihydroxy-3-sulfooxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C12H19NO17S2 (513.0094)


   

2,5-Diaminopyrimidine nucleoside triphosphate

2,5-Diaminopyrimidine nucleoside triphosphate

C9H18N5O14P3 (513.0063)


   

2,5-diamino-6-ribosylamino-4(3H)pyrimidinone 5-triphosphate

2,5-diamino-6-ribosylamino-4(3H)pyrimidinone 5-triphosphate

C9H18N5O14P3 (513.0063)


A ribose 5-triphosphate compound having a 2,5-diamino-6-oxo-1,6-dihydropyrimidin-4-ylamino substituent at the 1-position.